Our platform technologies facilitate the optimization of novel microorganisms and genes found in nature to enable product solutions for the Dermo-cosmetic, pharmaceutical, food industrial, environmental, and agricultural markets. ProBionic is targeting key multi-billion dollar segments where the company believes its technologies and products will create high value and competitive advantages for strategic partners and customers.

 

Since our founding in 2000, proBionic has emerged as a leader in the molecular systematics of microorganisms for the creation of improved new functional probiotics and microbial products. For example, we contributed the largest share in the world of the industrial starters for Kimchi fermentation. Recently, we completed the development of the functional plant origin Latobacillus sakei probio 65 whose phase III study was completed for the atopic dermatitis. We have a strong pipeline of potential products including personalized medical healthcare in commercial market. In addition to that, our high-quality products have been directly provided to our customers through the internet shopping malls. Our strategic partners and major customers are market leaders including Daesang FNF, Pulmuwon Co., Cargill Purina Inc., CJ Corp., Theragen Bio Institute, and Genomictree Co. We are also looking forward to the promising results obtained in the production of bio-energy through the utilization of algae as our venture in future.